We are developing machine learning models for drug discovery and software for facilitating and automating research in the life-sciences industry.
Employees: 11-50
Total raised: $11M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | MSIVC | msivc.co.j... |
| - | J-Startup | j-startup.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.09.2021 | Series A | $11M | - |
Mentions in press and media 6
| Date | Title | Description |
| 21.07.2026 | SyntheticGestalt Launches Molecular AI Models ZAO and KOYA | Available through the NVIDIA BioNeMo Agent Toolkit, advancing drug discovery where AI agents and researchers work together MINATO CITY, TOKYO, JAPAN, July 21, 2026 /EINPresswire.com/ -- Molecular AI developer, SyntheticGestalt (headquarters... |
| 11.01.2024 | SyntheticGestalt and Enamine to Collaborate on the Creation of AI-Based Model to Facilitate Drug Discovery | SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates. This model will utilize 38 billion compounds from Enamine REAL database as a dataset for pre-training. TOKYO and KYIV, Ukraine, Jan. 11... |
| 11.01.2024 | Enamine and SyntheticGestalt to Collaborate on the Creation of AI-Based Model to Facilitate Drug Discovery | KYIV, UKRAINE , January 11, 2024 /EINPresswire.com/ -- 𝘚𝘺𝘯𝘵𝘩𝘦𝘵𝘪𝘤𝘎𝘦𝘴𝘵𝘢𝘭𝘵 𝘸𝘪𝘭𝘭 𝘥𝘦𝘷𝘦𝘭𝘰𝘱 𝘢 𝘱𝘳𝘦-𝘵𝘳𝘢𝘪𝘯𝘦𝘥 𝘈𝘐 𝘮𝘰𝘥𝘦𝘭 𝘵𝘰 𝘥𝘪𝘴𝘤𝘰𝘷𝘦𝘳 𝘴𝘺𝘯𝘵𝘩𝘦𝘴𝘪𝘻𝘢𝘣𝘭𝘦 𝘥𝘳𝘶𝘨-𝘭𝘪𝘬𝘦 𝘩𝘪𝘵 𝘤𝘢𝘯𝘥𝘪𝘥𝘢𝘵𝘦𝘴. 𝘛𝘩𝘪𝘴 𝘮𝘰𝘥𝘦𝘭 𝘸𝘪𝘭𝘭 𝘶𝘵𝘪𝘭𝘪𝘻𝘦 38 ...... |
| 11.01.2024 | SyntheticGestalt, Inc. Enamine and SyntheticGestalt collaborate to create AI-based models to accelerate drug discovery | - |
| 11.01.2024 | SyntheticGestalt, Inc. Enamine and SyntheticGestalt collaborate to create AI-based models to accelerate drug discovery | Synthetic Gestalt Co., Ltd. Enamine and SyntheticGestalt collaborate to create AI-based models to accelerate drug discovery ~ Developing the world’s largest pre-learning model based on the 3D structure of compounds ~ …… SyntheticGestalt use... |
| 11.01.2024 | Collaborative Innovation: SyntheticGestalt and Enamine Unite for AI-Driven Drug Discovery Model | SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates. This model will utilize 38 billion compounds from Enamine REAL database as a dataset for pre-training. SyntheticGestalt, a research and... |